Advisory panel to decide fate of Johnson & Johnson COVID vaccine

Advisory panel to decide fate of Johnson & Johnson COVID vaccine


Whether Johnson & Johnson’s COVID-19 vaccine is back in use this weekend will depend on a recommendation expected Friday by a federal advisory panel.

J&J’s one-shot vaccines were put on hold last week after reports of blood clots in a handful of recipients, including one death.

The decision to reinstate the vaccine is in the hands of the Advisory Committee on Immunization Practices, which meets on Friday at 11 am.

Trending: The Penalty For Treason? Here’s What You Said!

The committee, which includes doctors and public-health officials, is expected to vote on their recommendation by 5 pm, according to reports.

From there, the group is expected to advise the Food and Drug Administration and Centers for Disease Control and Prevention to either continue or lift the pause.

A recommendation to lift the pause and an agreement by the FDA and CDC may bring the vaccine back into circulation as early as this weekend, making it possible for vaccination sites, which have stocked millions of doses, to

Continue reading

You Might Like

Do NOT follow this link or you will be banned from the site!
Thanks for sharing!
Send this to a friend